• East Value Research set a 12-month target price of EUR 0.92 for Warimpex, implying 79.5% upside.
• H1 2026 results improved, but net income would have been negative without a EUR 3.9 million remeasurement gain on Mogilska 31.
• Mogilska 31 apartment sales stayed flat; 57 units sold, three reserved; pace seen at 1-2 units monthly.
• Warimpex’s net debt rose to EUR 149.4 million from EUR 147.9 million at end-2025; report flags rising interest-rate pressure.
• East Value cut 2026 revenue view to EUR 21.3 million; net income forecast reduced to EUR 90,000.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Warimpex Finanz- und Beteiligungs AG published the original content used to generate this news brief via EQS News (Ref. ID: rc_26738) on September 03, 2026, and is solely responsible for the information contained therein.